Janssen’s Spravato Enters US Market With Enhanced REMS And Plans For A Monotherapy Trial

 
• By Sue Sutter
Spravato manufacturing
Janssen is manufacturing Spravato in anticipation of a US roll-out starting in mid-March. • Source: Janssen

More from Approvals

More from Product Reviews